Drug intelligence / Profile preview

ademetionine butanedisulfonate

Development stage
Phase 3
Lead developer
Abbott
Modality
Small Molecules
Administration
Intramuscular, Intravenous, Oral, Subcutaneous
01

Overview

Ademetionine butanedisulfonate is a stable salt form of S-adenosyl-L-methionine (SAMe), an endogenous amino acid derivative present in virtually all body tissues and fluids. It serves as a primary methyl donor in transmethylation reactions and a precursor for physiological sulfur compounds (such as glutathione, cysteine, taurine, and coenzyme A) via transsulfuration. In the liver, ademetionine regulates hepatocyte membrane fluidity by methylating membrane phospholipids and enhances detoxification by increasing glutathione levels. It is clinically approved for the treatment of intrahepatic cholestasis in pre-cirrhotic and cirrhotic states, intrahepatic cholestasis of pregnancy, and depressive symptoms.

Brand names
AdemtaBaixinuoCereliv-HumanityCirrosamDonametGepsamHepamethionHeptolanHeptralSamyrTransmetil
Other names
AdoMetSAMSAMeS-adenosyl-L-methionine 1,4-butanedisulfonateS-adenosyl-L-methionine butanedisulfonateS-adenosylmethionine 1,4-butanedisulfonateS-adenosylmethionine butanedisulfonateademetionine 1,4-butanedisulfonateademetionine butanedisulfonate
02

Targets

COMT (Catechol-O-methyltransferase)DNMT (DNA methyltransferase)KMT (Histone-lysine methyltransferases)PEMT (Phosphatidylethanolamine N-methyltransferase)PDE4B (3',5'-cyclic-AMP phosphodiesterase 4B)PP2A (Protein phosphatase 2A)

Beyond the preview

Go deeper on ademetionine butanedisulfonate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ademetionine butanedisulfonate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call